PRESS RELEASE published on 09/03/2024 at 14:30, 1 year 3 months ago Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1 MHRA authorizes Moderna's updated COVID-19 vaccine targeting JN.1 variant. Available for NHS and private purchase in the UK. Follows WHO recommendation for JN.1 subvariants COVID-19 Vaccine Moderna JN.1 Variant MHRA Authorization Private Purchase
BRIEF published on 09/02/2024 at 13:05, 1 year 3 months ago Taiwan FDA Approves Moderna’s COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1 COVID-19 Vaccine Moderna Spikevax Taiwan FDA SARS-CoV-2 JN.1
BRIEF published on 09/02/2024 at 13:05, 1 year 3 months ago La FDA de Taïwan approuve le vaccin COVID-19 de Moderna ciblant la variante JN.1 du SRAS-CoV-2 Moderne Vaccin Contre Le Covid-19 Spikevax SARS-CoV-2 JN.1 FDA De Taïwan
PRESS RELEASE published on 09/02/2024 at 13:00, 1 year 3 months ago Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 Moderna receives approval for updated COVID-19 vaccine formulation targeting SARS-CoV-2 variant JN.1 from Taiwan FDA. Regulatory decisions globally expected soon COVID-19 Vaccine Moderna Spikevax SARS-CoV-2 Variant Taiwan FDA
BRIEF published on 08/29/2024 at 14:05, 1 year 3 months ago Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination COVID-19 Moderna Vaccination Health Campaign Public Awareness
BRIEF published on 08/29/2024 at 14:05, 1 year 3 months ago Moderna lance une campagne nationale de sensibilisation pour favoriser la vaccination contre la COVID-19 Moderne COVID 19 Vaccination Campagne De Santé Sensibilisation Du Public
PRESS RELEASE published on 08/29/2024 at 14:00, 1 year 3 months ago Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination Moderna launches 'Do It For You & Them' campaign to drive vaccination rates in the U.S. and inform about COVID-19 risks & impact, updated vaccines available for KP.2 variant COVID-19 Moderna Awareness Campaign KP.2 Variant Vaccination Rates
BRIEF published on 08/23/2024 at 13:05, 1 year 3 months ago Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R) Public Health European Commission MRNA Technology RSV Vaccine Moderna Approval
BRIEF published on 08/23/2024 at 13:05, 1 year 3 months ago Moderna reçoit l'approbation de la Commission européenne pour son vaccin contre le VRS mRESVIA(R) Santé Publique Vaccin Contre Le VRS Commission Européenne Technologie De L'ARNm Approbation De Moderna
PRESS RELEASE published on 08/23/2024 at 13:00, 1 year 3 months ago Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R) Moderna receives European Commission approval for mRESVIA(R) (mRNA-1345) vaccine to fight RSV in adults aged 60+; significant breakthrough beyond COVID-19 European Commission Moderna Vaccine RSV MRESVIA
Published on 12/06/2025 at 02:00, 3 hours 22 minutes ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 4 hours 7 minutes ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 4 hours 57 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 5 hours 22 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 5 hours 52 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:15, 7 hours 7 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 7 hours 10 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 10 hours 24 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 11 hours 7 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 6 hours 22 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 6 hours 22 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 6 hours 22 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 6 hours 22 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 12 hours 4 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
